RUNX2 and bone cancer: In bone cancer, YBX1 stabilizes pro-metastatic mRNA by recognizing sequence motifs shared by the 3’ end of tRNA fragments(tRF)-GlyTCC and RUNX2, thereby inhibiting tumor metastasis in primary bone cancer progression (15).